Stock KREBSBIO KREBS BIOCHEMICALS & INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Krebs Biochemicals & Industries Limited NSE India S.E.

Equities

KREBSBIO

INE268B01013

Market Closed - NSE India S.E.
Other stock markets
 05:13:54 01/07/2024 pm IST 		5-day change 1st Jan Change
73.45 INR +3.52% Intraday chart for Krebs Biochemicals & Industries Limited +4.17% -6.25%
21/05 Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer CI
21/05 Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023
Krebs Biochemicals Trims Net Loss in Fiscal Q4
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KREBSBIO Stock
  4. KREBSBIO Stock
  5. News Krebs Biochemicals & Industries Limited
  6. Other languages